Brad Pohlman

Stromal Gene Signatures in Large-B-Cell Lymphomas

Georg Lenz, George W. Wright, Sandeep S. Davé et al. · New England Journal of Medicine · 2008 · 1.8K citations · Full text

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

Thomas E. Witzig, Leo I. Gordon, Fernando Cabanillas et al. · Journal of Clinical Oncology · 2002 · 1.2K citations

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

Brian J. Bolwell, Ronald Sobecks, Brad Pohlman et al. · Bone Marrow Transplantation · 2004 · 203 citations

Mycophenolate Mofetil, Transplantation, Marrow Transplantation +9

A Phase <scp>II</scp> trial of Belinostat ( <scp>PXD</scp> 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

Francine M. Foss, Ranjana H. Advani, Madeleine Duvic et al. · British Journal of Haematology · 2014 · 187 citations · Full text

LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab

Yasodha Natkunam, Pedro Farinha, Eric D. Hsi et al. · Journal of Clinical Oncology · 2007 · 181 citations · Full text